Development of a Fucoidan-Specific Antibody and Measurement of Fucoidan in Serum and Urine by Sandwich ELISA
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Fucoidan exhibits various biological properties. We raised a novel antibody against fucoidan extracted from Cladosiphon okamuranus and developed a sandwich ELISA method to measure fucoidan. The fucoidan antibody was specific and did not cross-react with other polysulfated polysaccharides. Fucoidan recovery from serum and urine by ELISA was 86-113%. Intra- and inter-assay CVs were 1.5-13.4%. Assay linearity was maintained after 3-fold dilution of each sample with phosphate-buffer saline (PBS). In the serum and urine of healthy volunteers (n=10), fucoidan was not detected before administration, and the levels markedly increased 6 and 9 h after oral administration. The molecular weight of the serum fucoidan determined by HPLC gel filtration remained unchanged, whereas that of urine fucoidan was significantly reduced. This is the first ELISA method of measuring serum and urine fucoidan levels after oral administration. The method is simple, reliable, and practical for the analysis of samples, especially urine samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of the biochemistry of heavy metal biosorption by brown algae
Davis, T. A., Volesky, B., & Mucci, A. (2003) · Water Research · doi:10.1016/s0043-1354(03)00293-8 · Cited by 2,394
Structural study of fucoidan from Cladosiphon okamuranus tokida
Nagaoka, M., Shibata, H., Kimura-Takagi, I., Hashimoto, S., Kimura, K., Makino, T., Aiyama, R., Ueyama, S., & Yokokura, T. (1999) · Glycoconjugate Journal · doi:10.1023/a:1006945618657 · Cited by 173
Maruyama, H., Tamauchi, H., Iizuka, M., & Nakano, T. (2006) · Planta Medica · doi:10.1055/s-2006-951703 · Cited by 151
A quantitative method to detect fucoidan in human plasma using a novel antibody
Irhimeh, M. R., Fitton, J. H., Lowenthal, R. M., & Kongtawelert, P. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.10.948919 · Cited by 121
New natural polysaccharides with potent antithrombic activity: Fucans from brown algae
Grauffel, V., Kloareg, B., Mabeau, S., Durand, P., & Jozefonvicz, J. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90127-0 · Cited by 100
Shimanaka, K., Ikai, K., Kato, I., Sakai, T., & Ishizuka, K. (2003) · Marine Biotechnology · doi:10.1007/s10126-002-0107-9 · Cited by 83
Cited by
Therapies from Fucoidan: An Update
Fitton, J., Stringer, D., & Karpiniec, S. (2015) · Marine Drugs · doi:10.3390/md13095920 · Cited by 418
Therapies from Fucoidan; Multifunctional Marine Polymers
Fitton, J. H. (2011) · Marine Drugs · doi:10.3390/md9101731 · Cited by 392
Therapeutic Effects of Fucoidan: A Review on Recent Studies
Luthuli, S., Wu, S., Cheng, Y., Zheng, X., Wu, M., & Tong, H. (2019) · Marine Drugs · doi:10.3390/md17090487 · Cited by 391
Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Atashrazm, F., Lowenthal, R., Woods, G., Holloway, A., & Dickinson, J. (2015) · Marine Drugs · doi:10.3390/md13042327 · Cited by 358
Immunomodulatory and Anti-Inflammatory Effects of Fucoidan: A Review
Apostolova, E., Lukova, P., Baldzhieva, A., Katsarov, P., Nikolova, M., Iliev, I., Peychev, L., Trica, B., Oancea, F., Delattre, C., et al. (2020) · Polymers · doi:10.3390/polym12102338 · Cited by 345
Emergent Sources of Prebiotics: Seaweeds and Microalgae
De Jesus Raposo, M., De Morais, A., & De Morais, R. (2016) · Marine Drugs · doi:10.3390/md14020027 · Cited by 331
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
Van Weelden, G., Bobiński, M., Okła, K., Van Weelden, W. J., Romano, A., & Pijnenborg, J. M. A. (2019) · Marine Drugs · doi:10.3390/md17010032 · Cited by 330
Shang, Q., Song, G., Zhang, M., Shi, J., Xu, C., Hao, J., Li, G., & Yu, G. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.11.002 · Cited by 258
Therapies from Fucoidan: New Developments
Fitton, J. H., Stringer, D. N., Park, A. Y., & Karpiniec, S. S. (2019) · Marine Drugs · doi:10.3390/md17100571 · Cited by 225
Zhang, Z., Teruya, K., Eto, H., & Shirahata, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027441 · Cited by 167
“8 kDa was detected without degradation in subjects’ serum, plasma, and urine 6 h after oral administration [58].”
BackgroundIntestinal Absorption of Fucoidan Extracted from the Brown Seaweed, Cladosiphon okamuranus
Nagamine, T., Nakazato, K., Tomioka, S., Iha, M., & Nakajima, K. (2014) · Marine Drugs · doi:10.3390/md13010048 · Cited by 160
Self-citationThe prebiotic potential of polysaccharides and extracts of seaweeds
Zaporozhets, T. S., Besednova, N. N., Kuznetsova, T. A., Zvyagintseva, T. N., Makarenkova, I. D., Kryzhanovsky, S. P., & Melnikov, V. G. (2014) · Russian Journal of Marine Biology · doi:10.1134/s1063074014010106 · Cited by 98
The Pharmacokinetics of Fucoidan after Topical Application to Rats
Pozharitskaya, O. N., Shikov, A. N., Obluchinskaya, E. D., & Vuorela, H. (2019) · Marine Drugs · doi:10.3390/md17120687 · Cited by 79
“Based on previously published data [25], the anti-Xa activity was selected as the biomarker for our study of pharmacokinetics of fucoidan.”
MethodTocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71
Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus
Nagamine, T., Kadena, K., Tomori, M., Nakajima, K., & Iha, M. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1943 · Cited by 27
Self-citation
Metadata
- Authors
- TOKITA, Y., NAKAJIMA, K., MOCHIDA, H., IHA, M., & NAGAMINE, T.
- Venue
- Bioscience, Biotechnology, and Biochemistry
- Publisher
- Informa UK Limited
- Published
- 2010-02-23
- Volume
- 74
- Issue
- 2
- Pages
- 350-357
- ISSN
- 0916-8451 (ISSN-L)
- 1347-6947
- OpenAlex
- W2104041255
- Cited by
- 118
- References
- 6
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.